|
|
Article: Graffinity Pharmaceuticals Appoints Mathias Woker as Vice President Of Business Development for the U.S.A. - Drug Discovery Company Expands Management Team With Dedicated Focus on U.S. Business -.
- Article from:
- PR Newswire
- Article date:
- November 12, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HEIDELBERG, Germany, Nov. 12 /PRNewswire/ -- Graffinity Pharmaceuticals AG today announced that it has named Mathias Woker to the newly created position of Vice President, Business Development USA. In this role, Mr. Woker, who will be based in Boston, Massachusetts, will oversee Graffinity's business development activities in the United States. Mr. Woker will report to Dr. Klaus Schollmeier, Chief Executive Officer of Graffinity. Dr. Helmut Kessmann, Graffinity's Chief Business Officer, will focus on Europe and Asia and have additional capacity to pursue strategic growth opportunities for the company.
"Matt has proven abilities, in both the business and legal ...